Pharmala Biotech Holdings Inc. (CSE:MDMA) is listed on the Canadian Securities Exchange in the Life Sciences sector, since January 11, 2022. The CSE has covered it in 2 stories and one CSE TV video since 2022.
CSE:MDMACompany profile on thecse.com
Also in these stories: Abound Energy Inc. (CSE:ABND), Avanti Gold Corp. (CSE:AGC), Rocket Doctor AI Inc. (CSE:AIDR), Abitibi Metals Corp. (CSE:AMQ), Appia Rare Earths & Uranium Corp (CSE:API), Ares Strategic Mining Inc. (CSE:ARS)
January Highlights As 2025 comes to an end, we’re sharing our favourite highlights from another incredible year at the CSE. In January, we hit the ground running with a strong presence at VRIC, hosted our signature Mining Over Canada Reception, joined global financial market leaders on the slopes of the Italian Alps, and released our…
Abound Energy Inc. (CSE:ABND) and 83 more
The CSE warmly welcomed PharmAla Biotech Holdings Inc. (CSE:MDMA) for a virtual Market Open on January 26, 2022. PharmAla is focused on the manufacturing of active pharmaceutical ingredients of the substituted methylenedioxy- phenethylamines class (MDXX), including 3,4-methylenedioxymethamphetamine (MDMA). PharmAla also intends to develop novel formulations of MDMA and MDXX, as well as novel drug delivery…
Pharmala Biotech Holdings Inc. (CSE:MDMA)
